(Q68320898)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3358818%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

title

Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by Bruneau et al (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3358818%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

Complications of oral contraceptives and antiphospholipid antibodies: reply to the letter by bruneau et a1 (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

31 December 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

31 December 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

31 December 2022

1

R A Asherson

1 reference

23 September 2019

3

G R Hughes

1 reference

23 September 2019

2

E N Harris

1 reference

23 September 2019

G. R. Hughes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3358818

31 December 2022

R. G. Farquharson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A3358818

31 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=3358818

31 December 2022

publication date

1 April 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3358818%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

23 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780310424

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

https://onlinelibrary.wiley.com/doi/full/10.1002/art.1780310424

31 December 2022

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

31 December 2022

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3358818%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3358818%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3358818%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

page(s)

575-576

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3358818%20AND%20SRC:MED&resulttype=core&format=json

Oral contraceptives, blood clotting and thrombosis

23 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

Oral contraceptives and cardiovascular disease: some questions and answers.

31 December 2022

2

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

The Journal of Rheumatology

31 December 2022

4

5

448

Travers

1978

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

Antibodies to cardiolipin and vascular complications in women taking oral contraceptives

31 December 2022

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

Systemic lupus erythematosus, antiphospholipid antibodies, chorea, and oral contraceptives

31 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis

31 December 2022

8

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

Cerebral infarction associated with lupus anticoagulants--preliminary report

31 December 2022

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780310424

31 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3358818%20AND%20SRC:MED&resulttype=core&format=json

23 September 2019

1 reference